Neuroscience 2025

GemPharmatech is exhibiting at Society for Neuroscience's Neuroscience 2025, taking place November 16-19 in San Diego, California. Visit us at Booth 3225 to explore how our advanced neurological mouse models are accelerating discovery in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. 

During the conference, our scientific team will be on hand to share insights into model validation, study design, and translational applications that support drug discovery and efficacy evaluation. Whether you’re investigating neuroinflammation, synaptic function, or neurodegeneration, GemPharmatech provides the precision and data-driven expertise to help you reach your research goals.

Find us at Booth 3225 to learn about our latest research innovations, explore our extensive catalog of validated neurological models, and discuss your specific research challenges with our experts.

Don’t miss our poster presentation during Neuroscience 2025! 

#7698 “Development of Fully Human CD98hc Antibodies to Enhance Delivery of Therapeutic Drugs across the Blood-Brain Barrier”

• Presentation Number: PSTR309.12

• Posterboard Number: VV11

• Date and Time: November 18, 2025, 8:00 a.m. - 12:00 p.m.

• Location: SDCC Halls B-H

#9210 “A Novel Patient-derived Pre-clinical Mouse Model for Myasthenia Gravis”

• Presentation Number: PSTR330.11

• Posterboard Number: G14

• Date and Time: November 18, 2025, 1:00 p.m. - 5:00 p.m.

• Location: SDCC Halls B-H

Ready to accelerate your preclinical program? Email us at sales@gempharmatech.com to schedule a one-on-one meeting in advance. Our team will be available throughout the conference to discuss your neurological research needs and custom model development options.

Explore GemPharmatech’s Portfolio of Neurological Disease Models

Discover our validated mouse models designed to advance studies in neurodegeneration, cognitive decline, and behavioral neuroscience. Learn how our transgenic, knock-in, and humanized models are driving innovation in drug discovery and disease mechanism research.

Learn more

On-Demand Webinar

Unlock the potential of preclinical ALS research with advanced mouse models

Join GemPharmatech’s Dr. Shan Lin as she examines the advantages of using humanized and disease-specific ALS models to bridge translational gaps in therapeutic development. Gain insights into how these models enhance the predictability of preclinical studies and support clinical translation.

Watch now